{"company":{"id":689188,"name":"Pathos","domain":"pathos.com","url":"https://alion.io/company/pathos"},"section":"news","answer":"Pathos: 17 headlines on record, 1 headline in the last 90 days. Its story counts 6 milestones.","figures":[{"label":"Headlines","value":"17"},{"label":"In 90 days","value":"1"},{"label":"Milestones","value":"6"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":17},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":6}],"news":[{"date":"2026-09-11","kind":"News","title":"Pathos Communications: H1 Revenue Rises 14% To $7.3 Million As Adjusted EBITDA Jumps 36%","source":"Pulse 2.0","url":"https://pulse2.com/pathos-communications-h1-revenue-rises-14-to-7-3-million-as-adjusted-ebitda-jumps-36/"},{"date":"2026-08-04","kind":"News","title":"Pathos AI signs two cancer deals with Alphamab and AZ","source":"pharmaphorum","url":"https://pharmaphorum.com/news/pathos-ai-signs-two-cancer-deals-alphamab-and-az"},{"date":"2026-08-04","kind":"Blog","title":"Pathos AI Enters Global Licensing Agreement with Alphamab Oncology on JSKN016, a First-in-Class TROP2/HER3 Bispecific ADC","url":"https://pathos.com/pathos-ai-enters-global-licensing-agreement-with-alphamab-oncology-on-jskn016-a-first-in-class-trop2-her3-bispecific-adc"},{"date":"2026-08-04","kind":"Blog","title":"Pathos AI Enters Collaboration and Co-Exclusive Licensing Agreement to Advance Novel ERα PROTAC for ER+ Breast Cancer into the Clinic","url":"https://pathos.com/pathos-ai-enters-collaboration-and-co-exclusive-licensing-agreement-to-advance-novel-er-protac-for-er-breast-cancer-into-the-clinic"},{"date":"2026-05-06","kind":"Press release","title":"Pathos AI Acquires Majority Stake in DeuterOncology to Advance Next-Generation MET Inhibitor Identified by Pathos Foundry Platform","url":"https://pathos.com/pathos-ai-acquires-majority-stake-in-deuteroncology-to-advance-next-generation-met-inhibitor-identified-by-pathos-foundry-platform"},{"date":"2025-05-16","kind":"Press release","title":"Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI","url":"https://pathos.com/pathos-ai-secures-365-million-in-series-d-financing-to-advance-oncology-drug-development-through-ai"},{"date":"2025-05-16","kind":"News","title":"AI-powered drug development startup Pathos AI closes $365M investment","source":"SiliconANGLE","url":"https://siliconangle.com/2025/05/15/ai-powered-drug-development-startup-pathos-ai-closes-365m-investment/"},{"date":"2025-05-09","kind":"Blog","title":"Pathos AI Appoints Iker Huerga as Chief Executive Officer to Lead the Next Era of AI-Enabled Drug Development","url":"https://pathos.com/pathos-ai-appoints-iker-huerga-as-chief-executive-officer-to-lead-the-next-era-of-ai-enabled-drug-development"},{"date":"2025-04-24","kind":"News","title":"AstraZeneca joins Tempus, Pathos in cancer AI project","source":"pharmaphorum","url":"https://pharmaphorum.com/news/astrazeneca-joins-tempus-pathos-cancer-ai-project"},{"date":"2025-04-23","kind":"Blog","title":"Pathos Signs Strategic Agreements with AstraZeneca and Tempus to Develop the Largest Multimodal Foundation Model in Oncology","url":"https://pathos.com/pathos-signs-strategic-agreements-with-astrazeneca-and-tempus-to-develop-the-largest-multimodal-foundation-model-in-oncology"},{"date":"2025-03-20","kind":"Blog","title":"Pathos AI Doses First Patient in Phase 1b/2a Clinical Trial of Pocenbrodib, a CBP/p300 Inhibitor","url":"https://pathos.com/pathos-ai-doses-first-patient-in-phase-1b-2a-clinical-trial-of-pocenbrodib-a-cbp-p300-inhibitor"},{"date":"2024-10-29","kind":"Press release","title":"Pathos AI Closes $62M Oversubscribed Series C Round of Financing to Accelerate its Platform Approach to Drug Development","url":"https://pathos.com/pathos-ai-closes-62m-oversubscribed-series-c-round-of-financing-to-accelerate-its-platform-approach-to-drug-development"},{"date":"2024-08-15","kind":"Blog","title":"Pathos Expands Pipeline With Worldwide License of Phase 2-ready Program, a Brain-penetrant, PRMT5 Inhibitor","url":"https://pathos.com/pathos-expands-pipeline-with-worldwide-license-of-phase-2-ready-program-a-brain-penetrant-prmt5-inhibitor"},{"date":"2024-01-26","kind":"Press release","title":"Pathos AI Completes Acquisition of Rain Oncology","url":"https://pathos.com/pathos-ai-completes-acquisition-of-rain-oncology"},{"date":"2023-12-14","kind":"News","title":"Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights","source":"YahooFinance","url":"https://finance.yahoo.com/news/rain-oncology-enters-agreement-acquired-230500089.html"},{"date":"2023-12-14","kind":"News","title":"Rain Oncology to be acquired by Pathos AI for $1.16 in cash per share","source":"seekingalpha.com","url":"https://seekingalpha.com/news/4046221-rain-oncology-to-be-acquired-by-pathos-ai-for-116-in-cash-per-share"},{"date":"2023-05-23","kind":"Blog","title":"Pathos Launches Precision Oncology Pipeline With License of First Phase I Program, a CBP/p300 Inhibitor","url":"https://pathos.com/pathos-launches-precision-oncology-pipeline-with-license-of-first-phase-i-program-a-cbp-p300-inhibitor"}],"story":[{"title":"Raised a round Venture round $283M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1967854/000196785425000001/"},{"title":"Raised a round Venture round $62M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1967854/000196785424000001/"},{"title":"Launched Pathos Launches Precision Oncology Pipeline With License of First Phase I Program, a CBP/p300 Inhibitor · pathos.com","url":"https://pathos.com/pathos-launches-precision-oncology-pipeline-with-license-of-first-phase-i-program-a-cbp-p300-inhibitor"},{"title":"New executive Eric Lefkofsky, Executive Officer, Director · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1967854/000196785423000001/"},{"title":"Raised a round Venture round $20M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1967854/000196785423000001/"},{"title":"Founded"}],"as_of":"2026-11-14","cite":"Pathos, News. Alion, Nov 14, 2026. https://alion.io/company/pathos/news","html_url":"https://alion.io/company/pathos/news","json_url":"https://alion.io/company/pathos/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-14T23:32:37Z"}}